These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7036753)

  • 1. Effects of amino acids and gastric inhibitory polypeptide on insulin release in dogs.
    Yovos JG; O'Dorisio TM; Pappas TN; Cataland S; Thomas FB; Mekhjian H; Carey LC
    Am J Physiol; 1982 Jan; 242(1):E53-8. PubMed ID: 7036753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of gastric inhibitory polypeptide on leucine- and arginine-stimulated insulin release.
    Mazzaferri EL; Ciofalo L; Waters LA; Starich GH; Groshong JC; DePalma L
    Am J Physiol; 1983 Aug; 245(2):E114-20. PubMed ID: 6349379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbachol modulates GIP-mediated insulin release from rat pancreatic lobules in vitro.
    McCullough AJ; Marshall JB; Bingham CP; Rice BL; Manning LD; Kalhan SC
    Am J Physiol; 1985 Mar; 248(3 Pt 1):E299-303. PubMed ID: 3883800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic gastric inhibitory polypeptide. Stimulatory effect on insulin and glucagon secretion in the rat.
    Taminato T; Seino Y; Goto Y; Inoue Y; Kadowaki S
    Diabetes; 1977 May; 26(5):480-4. PubMed ID: 323091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of (Pro-)insulin biosynthesis and release by gastric inhibitory polypeptide in isolated islets of rat pancreas.
    Schäfer R; Schatz H
    Acta Endocrinol (Copenh); 1979 Jul; 91(3):493-500. PubMed ID: 382725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bethanechol prevents inhibition of gastric acid secretion by gastric inhibitory polypeptide.
    Soon-Shiong P; Debas HT; Brown JC
    Am J Physiol; 1984 Aug; 247(2 Pt 1):G171-5. PubMed ID: 6147097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of gastric inhibitory polypeptide and insulin secretion.
    Williams RH; May JM; Biesbroeck JB
    Metabolism; 1981 Jan; 30(1):36-40. PubMed ID: 7007799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of gastric inhibitory polypeptide (GIP) and cholecystokinin (CCK-8) with basal and stimulated insulin secretion in mice.
    Ahrén B; Hedner P; Lundquist I
    Acta Endocrinol (Copenh); 1983 Jan; 102(1):96-102. PubMed ID: 6130663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cholecystokinin, gastric inhibitory polypeptide, and secretin on insulin and glucagon secretion in rats.
    Szecówka J; Lins PE; Efendić S
    Endocrinology; 1982 Apr; 110(4):1268-72. PubMed ID: 7037370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of gastric inhibitory polypeptide, glucose, and arginine on insulin and glucagon secretion from the perfused rat pancreas.
    Pederson RA; Brown JC
    Endocrinology; 1978 Aug; 103(2):610-5. PubMed ID: 744105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide YY inhibits the insulinotropic action of gastric inhibitory polypeptide.
    Guo YS; Singh P; Draviam E; Greeley GH; Thompson JC
    Gastroenterology; 1989 Mar; 96(3):690-4. PubMed ID: 2644149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of somatostatin on release and insulinotropic action of gastric inhibitory polypeptide.
    Pederson RA; Dryburgh JR; Brown JC
    Can J Physiol Pharmacol; 1975 Dec; 53(6):1200-5. PubMed ID: 1222389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of secretion of gastric inhibitory polypeptide and insulin by intraduodenal amino acid perfusion.
    Thomas FB; Mazzaferri EL; Crockett SE; Mekhjian HS; Gruemer HD; Cataland S
    Gastroenterology; 1976 Apr; 70(4):523-7. PubMed ID: 815125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose-dependent insulinotropic polypeptide augmentation of insulin. Physiology or pharmacology?
    Sarson DL; Wood SM; Kansal PC; Bloom SR
    Diabetes; 1984 Apr; 33(4):389-93. PubMed ID: 6368294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical studies with gastric inhibitory polypeptide.
    Brown JC; Otte S
    World J Surg; 1979 Sep; 3(5):553-8. PubMed ID: 516774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of insulin secretory response to glucose-dependent insulinotropic polypeptide (GIP) by growth hormone in dogs.
    Pierluissi J; de Pierluissi R; de Martínez A
    Acta Cient Venez; 2002; 53(1):29-35. PubMed ID: 12216497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of gastric inhibitory polypeptide (GIP) on gastric acid secretion in dogs.
    Iinuma Y
    Gastroenterol Jpn; 1981; 16(1):33-8. PubMed ID: 6453035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral glucose augmentation of insulin secretion. Interactions of gastric inhibitory polypeptide with ambient glucose and insulin levels.
    Andersen DK; Elahi D; Brown JC; Tobin JD; Andres R
    J Clin Invest; 1978 Jul; 62(1):152-61. PubMed ID: 659629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of glucose-dependent insulinotropic polypeptide infused at physiological concentrations on the release of insulin in man.
    Sarson DL; Wood SM; Holder D; Bloom SR
    Diabetologia; 1982 Jan; 22(1):33-6. PubMed ID: 7037506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of glucagon, gastric inhibitory polypeptide, pancreatic polypeptide and somatostatin on beta-adrenergically induced insulin secretion in the mouse.
    Ahrén B; Lundquist I
    Diabete Metab; 1982 Sep; 8(3):209-12. PubMed ID: 6128264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.